SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021)
The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge d...
| Autores: | , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Conselleria de Salut i Consum del Govern de les Illes Balears |
| Repositorio: | Docusalut |
| Idioma: | inglés |
| OAI Identifier: | oai:docusalut.com:20.500.13003/19816 |
| Acceso en línea: | https://hdl.handle.net/20.500.13003/19816 |
| Access Level: | acceso abierto |
| Palabra clave: | Neoplasm Staging Rectum Neoplasms, Second Primary Chemoradiotherapy Neoadjuvant Therapy Humans Antineoplastic Combined Chemotherapy Protocols Rectal Neoplasms Humanos Recto Protocolos de Quimioterapia Combinada Antineoplásica Neoplasias del Recto Estadificación de Neoplasias Neoplasias Primarias Secundarias Quimioradioterapia Terapia Neoadyuvante Rectal cancer Total neoadjuvant therapy Guideline |
| Sumario: | The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge defining the better sequential strategy of surgery, radiotherapy and chemotherapy. The latest results of international phase III studies have positioned the total neoadjuvant therapy as a potential new standard of care in high risk rectal cancers, however, the best schedule is still not well defined. |
|---|